EG20085A - Process for preparing of imidazopyridine PAF/H2 antagonists - Google Patents

Process for preparing of imidazopyridine PAF/H2 antagonists

Info

Publication number
EG20085A
EG20085A EG8792A EG8792A EG20085A EG 20085 A EG20085 A EG 20085A EG 8792 A EG8792 A EG 8792A EG 8792 A EG8792 A EG 8792A EG 20085 A EG20085 A EG 20085A
Authority
EG
Egypt
Prior art keywords
pct
paf
antagonists
sec
imidazopyridine
Prior art date
Application number
EG8792A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG20085A publication Critical patent/EG20085A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
EG8792A 1991-02-13 1992-02-10 Process for preparing of imidazopyridine PAF/H2 antagonists EG20085A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919102997A GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents

Publications (1)

Publication Number Publication Date
EG20085A true EG20085A (en) 1997-05-31

Family

ID=10689943

Family Applications (1)

Application Number Title Priority Date Filing Date
EG8792A EG20085A (en) 1991-02-13 1992-02-10 Process for preparing of imidazopyridine PAF/H2 antagonists

Country Status (29)

Country Link
US (1) US5358953A (cg-RX-API-DMAC7.html)
EP (1) EP0572425B1 (cg-RX-API-DMAC7.html)
JP (1) JP2506541B2 (cg-RX-API-DMAC7.html)
KR (1) KR970005302B1 (cg-RX-API-DMAC7.html)
CN (1) CN1040326C (cg-RX-API-DMAC7.html)
AT (1) ATE109482T1 (cg-RX-API-DMAC7.html)
AU (1) AU650322B2 (cg-RX-API-DMAC7.html)
BR (1) BR9205615A (cg-RX-API-DMAC7.html)
CA (1) CA2099381C (cg-RX-API-DMAC7.html)
CZ (1) CZ280504B6 (cg-RX-API-DMAC7.html)
DE (1) DE69200304T2 (cg-RX-API-DMAC7.html)
DK (1) DK0572425T3 (cg-RX-API-DMAC7.html)
EG (1) EG20085A (cg-RX-API-DMAC7.html)
ES (1) ES2059212T3 (cg-RX-API-DMAC7.html)
FI (1) FI933531A7 (cg-RX-API-DMAC7.html)
GB (1) GB9102997D0 (cg-RX-API-DMAC7.html)
HU (2) HUT65947A (cg-RX-API-DMAC7.html)
IE (1) IE65125B1 (cg-RX-API-DMAC7.html)
IL (1) IL100887A (cg-RX-API-DMAC7.html)
MX (1) MX9200589A (cg-RX-API-DMAC7.html)
MY (1) MY108437A (cg-RX-API-DMAC7.html)
NO (1) NO300592B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ241597A (cg-RX-API-DMAC7.html)
PL (1) PL169304B1 (cg-RX-API-DMAC7.html)
RU (1) RU2114845C1 (cg-RX-API-DMAC7.html)
TW (1) TW227000B (cg-RX-API-DMAC7.html)
WO (1) WO1992014734A1 (cg-RX-API-DMAC7.html)
YU (1) YU48238B (cg-RX-API-DMAC7.html)
ZA (1) ZA921005B (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
AU3186395A (en) * 1994-08-10 1996-03-07 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives as dual histamine (h1) and platelet activating factor (paf) antagonists
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
MX9707187A (es) * 1995-08-05 1997-11-29 British Biotech Pharm Derivados de imidazopiridina.
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
ES2381775T3 (es) 2000-08-04 2012-05-31 Dmi Biosciences, Inc. Procedimiento del uso de dicetopiperazinas y composición que las contiene
CN101947306B (zh) 2003-05-15 2014-06-18 安皮奥制药股份有限公司 T-细胞介导的疾病的治疗
US7687515B2 (en) * 2006-01-17 2010-03-30 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
TWI429641B (zh) 2008-01-30 2014-03-11 Nippon Zoki Pharmaceutical Co 哌啶衍生物
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ,インコーポレイテッド ジケトピペラジンを用いた医薬組成物
CN103619839B (zh) * 2011-06-28 2016-06-01 福建省闽东力捷迅药业有限公司 抗-变态反应的苯并环庚并噻吩衍生物
EP2765968A4 (en) 2011-10-10 2015-01-21 Ampio Pharmaceuticals Inc IMPLANTABLE MEDICINE PRODUCTS WITH INCREASED IMMUNO TOLERANCE AND PROCESSING AND IMPLANTATION METHODS
KR102032400B1 (ko) 2011-10-10 2019-10-15 앰피오 파마슈티컬스 인코퍼레이티드 퇴행성 관절 질환의 치료
SG10201605205VA (en) * 2011-10-28 2016-08-30 Ampio Pharmaceuticals Inc Treatment of rhinitis
KR20150132508A (ko) 2013-03-15 2015-11-25 앰피오 파마슈티컬스 인코퍼레이티드 줄기세포의 가동화, 회귀, 증식 및 분화를 위한 조성물 및 이의 사용 방법
EP4066836A1 (en) 2014-08-18 2022-10-05 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
EP3310375A4 (en) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. USE OF LOW-MOLECULAR FRACTIONS OF HUMAN SERUMALBUMINE IN THE TREATMENT OF ILLNESSES
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (cg-RX-API-DMAC7.html) * 1963-04-24
AU616508B2 (en) * 1988-03-15 1991-10-31 G.D. Searle & Co. Benzyl-imidazo (4,5-c) pyridines
ATE141599T1 (de) * 1988-04-28 1996-09-15 Schering Corp Kondensierte polyzyklische verbindungen, zusammenstellungen, verfahren zur herstellung und deren anwendung als paf-antagonistische, antihistaminische und/oder anti-inflammatorische agenzien
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
CA2080476A1 (en) * 1990-05-09 1991-11-10 Anthony Marfat Azabenzimidazoles in the treatment of asthma, arthritis and related diseases

Also Published As

Publication number Publication date
CA2099381C (en) 1996-07-09
IL100887A0 (en) 1992-11-15
KR970005302B1 (ko) 1997-04-15
CN1040326C (zh) 1998-10-21
TW227000B (cg-RX-API-DMAC7.html) 1994-07-21
IE920449A1 (en) 1992-08-12
NO932889D0 (no) 1993-08-13
ES2059212T3 (es) 1994-11-01
FI933531A0 (fi) 1993-08-10
RU2114845C1 (ru) 1998-07-10
EP0572425B1 (en) 1994-08-03
ZA921005B (en) 1993-08-12
NO300592B1 (no) 1997-06-23
US5358953A (en) 1994-10-25
NO932889L (no) 1993-08-13
AU1168392A (en) 1992-09-15
NZ241597A (en) 1993-04-28
IL100887A (en) 1996-01-19
JP2506541B2 (ja) 1996-06-12
DE69200304D1 (de) 1994-09-08
CS42592A3 (en) 1992-09-16
DK0572425T3 (da) 1994-09-12
PL169304B1 (pl) 1996-06-28
FI933531L (fi) 1993-08-10
HUT65947A (en) 1994-08-29
MY108437A (en) 1996-09-30
JPH06504992A (ja) 1994-06-09
FI933531A7 (fi) 1993-08-10
IE65125B1 (en) 1995-10-04
HU9302327D0 (en) 1993-10-28
YU48238B (sh) 1997-08-22
EP0572425A1 (en) 1993-12-08
AU650322B2 (en) 1994-06-16
HU211202A9 (en) 1995-11-28
BR9205615A (pt) 1994-05-17
WO1992014734A1 (en) 1992-09-03
DE69200304T2 (de) 1994-12-08
ATE109482T1 (de) 1994-08-15
YU14392A (sh) 1994-11-15
CA2099381A1 (en) 1992-08-14
MX9200589A (es) 1992-10-01
GB9102997D0 (en) 1991-03-27
CN1064275A (zh) 1992-09-09
CZ280504B6 (cs) 1996-02-14

Similar Documents

Publication Publication Date Title
EG20085A (en) Process for preparing of imidazopyridine PAF/H2 antagonists
YU48426B (sh) Novi supstituisani pirazolilpirazoli, postupak njihovog dobijanja, medjuproizvodi za njihovo dobijanje i primena kao sredstava sa herbicidnim delovanjem
YU84791A (sh) Biciklicni 1-aza-cikloalkalni
ES2167371T3 (es) Derivados de 1h-3-aril-pirrolidin-2,4-diona espirociclicos substituidos.
DE69530094D1 (de) Thiazolidindione derivate, ihre herstellung und verwendung
MXPA02011418A (es) 1-aminoalquil-lactamas sustituidas y su uso como antagonistas del receptor muscarinico.
RU93054165A (ru) Производные имидазопиридина, способ их получения, фармацевтическая композиция, способ лечения
GB9000301D0 (en) Piperidine & pyrrolidine derivatives
SG164268A1 (en) Quinolin-4-yl derivatives i
EP0335979A4 (en) Thienopyrimidine derivatives
DE3855902D1 (de) Herstellungsverfahren für 2,5-Diamino-6-nitro-pyridinderivate sowie neue 2,5-Diamino-6-nitro-pyridinderivate
PT1018512E (pt) Novos derivados basicos de benzo¬e|isoindol-1-onas e pirrolo¬3,4-c|quinolin-1-onas com actividade antagonista de 5ht3 a sua preparacao e o seu uso terapeutico
YU4393A (sr) Supstituisani heksahidroazepinoni i tetrahidrobenzazepinoni
SE8801964D0 (sv) New 5-(omega-ammonio acyloxy methylene) tetrahydrofurans and tetrahydrothiophenes
MX9606654A (es) Derivados de alaquildiamina substituida y su uso como antagonistas de taquicinina.
GR75618B (cg-RX-API-DMAC7.html)
AU564799B2 (en) Composition for prophylactic and preventative of ketosis in livestock
PT100223A (pt) Processo para a preparacao de imidazopiridinas antagonistas de paf/h1
DE69006366D1 (de) BENZO[b]PHENANTHROLINDERIVATE, IHRE HERSTELLUNG UND IHRE THERAPEUTISCHE VERWENDUNG.
FI973558L (fi) Menetelmä terapeuttisesti käytt¦kelpoisten 2-metyyli-imidatsoÄ4,5-cÜpyrid-1-yylijohdannaisten valmistamiseksi
ATE110367T1 (de) Kalziumantagonisten.
GR70255B (cg-RX-API-DMAC7.html)
SE8403168L (sv) Karboxylsyraamidforeningar och derivat derav
KR840006998A (ko) 1,8-나프티리딘과 1.5,8-아자나프티리딘 유도체의 제조방법